SEATTLE, June 11, 2019 — Opus Biotech Communications is partnering with The Vanguard Leadership Group, of New York, to offer CEOs in emerging biotech, pharmaceutical and medical device companies a unique management program and services to help them achieve their business and professional development goals.

The Vanguard Group for Leadership supports senior executives as they build high-performance organizations and take their leadership, and their teams, to higher levels. Vanguard founder Ken Banta has been a principal leader of eight mergers and turnarounds, including the text-book transformations of Pharmacia Corporation and Schering-Plough.

Opus Biotech founders, Dan Eramian and Charles Craig, have been part of the biotech industry for the past 25 years working with CEOs in structuring PR, IR, public policy and crisis communications campaigns, as well as constructing ethical frameworks to guide executive decision making.

“Our alliance with Ken and his team will enable us to help CEOs through the many transformations that occur as their companies progress from start-up to clinical development to market approval,” said Eramian.

“Ken is an expert in supporting newer, as well as more experienced, CEOs and senior executives as they build their organizations,” said Craig.

In addition to advising clients on their communications strategy, Opus Biotech partner Penny Jo Welsch serves as the firm’s creative director helping companies develop web sites, investor decks, videos, infographics and social media strategy.

For more information on Opus Biotech and its alliance with The Vanguard Leadership Group contact Eramian (425-306-8716, danieleramian@comcast.net), or Craig (404-245-0591  charles.s.craig@gmail.com).